News & Analysis as of

Pharmaceutical Industry › Food and Drug Administration (FDA) › Counterfeit Drugs

Quarles & Brady LLP

Final Definitions and Considerations for Trading Partners to Prepare for DSCSA Implementation

Quarles & Brady LLP on

On March 16, 2023, the Food and Drug Administration (FDA) released final guidance regarding definitions of "suspect product" and "illegitimate product" as part of a continued effort to prepare trading partners for the...more

Oberheiden P.C.

Four Things that Healthcare Providers Need to Know About FDA Counterfeiting Investigations

Oberheiden P.C. on

The U.S. Food and Drug Administration (FDA) has broad authority to evaluate and approve drugs for medical use or prescription drugs. It also has the authority to investigate fake or counterfeit medicines and substances in the...more

Womble Bond Dickinson

Take a Bite out of Crime: There’s More than One Way to Stem the Flow of Counterfeit Medications

Womble Bond Dickinson on

A growing problem in the U.S. is the widespread availability of counterfeit medications, or fake prescription pills. These drugs, made to look like authentic prescription medications, may contain no active ingredient or any...more

Gibney Anthony & Flaherty, LLP

Online Safety: Avoiding Counterfeit COVID-19 Testing Kits

Gibney Anthony & Flaherty, LLP on

Almost as if on cue, as the United States ramps up testing and containment measures, US Customs and Border Protection (CBP) announced its first seizure of counterfeit COVID-19 test kits at the Los Angeles Airport...more

Mintz - Health Care Viewpoints

FDA Reports Results of Annual Crack Down on Illegal Internet Pharmacies

Mintz - Health Care Viewpoints on

Last week, FDA announced that more than 1,050 websites had illegal drugs and devices seized or received warning letters as part of the Eighth Annual International Internet Week of Action (IIWA). IIWA is an international...more

Troutman Pepper

Misbranded Drugs: A Danger To Physicians And Patients

Troutman Pepper on

Mail-order businesses, including pharmacies, bombard doctors by fax, phone, and Internet offering an assortment of name-brand medications and treatments at bargain prices. These new options tempt physicians with the promise...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide